An appraisal of the current scenario in vaccine research for COVID-19
journal contributionposted on 2023-05-21, 00:48 authored by Chong, WC, Chellappan, DK, Shukla, SD, Gregory PetersonGregory Peterson, Rahul PatelRahul Patel, Jha, NK, Rajaraman Eri, Dua, K, Tambuwala, MM, Madhur ShastriMadhur Shastri
The recent coronavirus disease 2019 (COVID-19) outbreak has drawn global attention, affecting millions, disrupting economies and healthcare modalities. With its high infection rate, COVID-19 has caused a colossal health crisis worldwide. While information on the comprehensive nature of this infectious agent, SARS-CoV-2, still remains obscure, ongoing genomic studies have been successful in identifying its genomic sequence and the presenting antigen. These may serve as promising, potential therapeutic targets in the effective management of COVID-19. In an attempt to establish herd immunity, massive efforts have been directed and driven toward developing vaccines against the SARS-CoV-2 pathogen. This review, in this direction, is aimed at providing the current scenario and future perspectives in the development of vaccines against SARS-CoV-2.
Department/SchoolSchool of Pharmacy and Pharmacology
Place of publicationSwitzerland
Rights statementCopyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International (CC BY) license (https://creativecommons.org/licenses/by/4.0/).